Glenmark's anti-diabetic drug biosimilar claims to cut therapy cost by 70%
The drug is being marketed under the brand name ‘Lirafit’, following approval from the Drug Controller General of India.
diabetes
January 2024
June 2023
May 2023
November 2021
February 2020
101.3 mn Indians could be diabetic, suggests new study
ICMR-INDIAB study assessed individuals aged 20 years and older drawn from urban and rural areas of 31 states, UTs, and the National Capital Territory
Public centres to provide standardised care to 75 million diabetes patients by 2025
India had 26,42,038 persons undergoing treatment for diabetes as on March 2023.
Walgreens to sell Biocon's insulin Semglee in the U.S.
Biocon Biologics targets to tap a $30 billion U.S. insulin market with two interchangeable insulins.
Long-term fatigue awaits diabetics hit by Covid-19
Presence of diabetes also influences post-Covid-19 syndrome and poses challenges in recovery of patients, says a study.
Cipla: Breath of new air
Structural changes in the global pharma industry are throwing up challenges and opportunities. Enter Cipla with its expertise in medicine, and vision for relevance beyond pharma.
